For patients undergoing noncardiac surgery, neurocognitive outcomes do not differ with hypotension-avoidance and hypertension-avoidance strategies.

Virtual consultations hold the potential to transform patient care; however, their capacity to fully replace face-to-face interactions remains uncertain. ten Haaft and colleagues present findings from ...

The FDA has granted approval to pembrolizumab for the treatment of adult patients with resectable, locally advanced HNSCC ...

A closed-loop glucose system improved glycemic control and reduced variability in patients undergoing major abdominal surgery ...

Pembrolizumab significantly reduced the risk of event free survival events by 30% compared with standard of care.

Merck & Co – known as MSD outside the US and Canada – has announced that its anti-PD-1 therapy Keytruda (pembrolizumab) has ...

Ravindra Uppaluri, MD, PhD, discusses findings from the KEYNOTE-689 trial in adult patients with resectable, locally advanced head and neck squamous cell carcinoma.